EFFICACY OF DUPILUMAB IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH TYPE 2 INFLAMMATION BY BASELINE BLOOD EOSINOPHIL COUNT

被引：0
|
作者：
Bafadhel, M. [1 ]
Bhatt, S. P. [2 ]
Rabe, K. F. [3 ,4 ,5 ]
Hanania, N. A. [6 ]
Vogelmeier, C. F. [7 ,8 ]
Cole, J. [9 ]
Christenson, S. A. [10 ]
Papi, A. [11 ]
Singh, D. [12 ]
Laws, E. [13 ]
Mortensen, E. R. [14 ]
Maloney, J. [14 ]
Lu, X. [13 ]
Bauer, D. [13 ]
Bansal, A. [14 ]
Robinson, L. B. [15 ]
Abdulai, R. M. [15 ]
机构：
[1] Kings Coll London, Fac Life Sci & Med, Kings Ctr Lung Hlth, Sch Immunol & Microbial Sci, London, England
[2] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA
[3] LungenClin Grosshansdorf, Grosshansdorf, Germany
[4] Christian Albrechts Univ Kiel, Kiel, Germany
[5] Airway Res Ctr North, German Ctr Lung Res, Grosshansdorf, Germany
[6] Baylor Coll Med, Sect Pulm & Crit Care Med, Houston, TX USA
[7] Philipps Univ Marburg, Dept Med Pulm & Crit Care Med, Marburg, Germany
[8] Ctr Lung Res DZL, Marburg, Germany
[9] OK Clin Res, Edmond, OK USA
[10] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA USA
[11] Univ Ferrara, Ferrara, Italy
[12] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester, Lancs, England
[13] Sanofi, Bridgewater, NJ USA
[14] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[15] Sanofi, Cambridge, MA USA
来源：
THORAX | 2023年 / 78卷 / SUPPL_4期
关键词：
D O I：
10.1136/thorax-2023-BTSabstracts.37
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S31
引用
收藏
页码：A25 / A26
页数：2
相关论文
共 50 条
  • [21] Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease
    Higham, Andrew
    Beech, Augusta
    Wolosianka, Sophie
    Jackson, Natalie
    Long, Gabriella
    Kolsum, Umme
    Southworth, Thomas
    Pham, Tuyet-Hang
    Sridhar, Sriram
    McCrae, Christopher
    Newbold, Paul
    Singh, Dave
    ALLERGY, 2021, 76 (06) : 1861 - 1864
  • [22] Type 2 Inflammation in Eosinophilic Chronic Obstructive Pulmonary Disease
    Higham, A. J.
    Wolosianka, S.
    Beech, A. S.
    Jackson, N.
    Long, G.
    Kolsum, U.
    Southworth, T.
    Pham, T.
    Sridhar, S.
    McCrae, C.
    Newbold, P.
    Singh, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] TOTAL EOSINOPHIL COUNT IN OBSTRUCTIVE PULMONARY-DISEASE
    LOWELL, FC
    NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (22): : 1182 - 1183
  • [24] Cost-effectiveness of single-inhaler triple therapy for chronic obstructive pulmonary disease treatment by baseline blood eosinophil count: IMPACT trial
    Shah, Dhvani
    Martin, Alan
    Kendall, Robyn
    Risebrough, Nancy
    Ismaila, Afisi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [25] The stability of blood eosinophil count and clinical outcomes in Thai chronic obstructive pulmonary disease patients: A prospective study
    Kaenmuang, Punchalee
    Juthong, Siwasak
    Densrisereekul, Sirikorn
    RESPIROLOGY, 2023, 28 : 14 - 15
  • [26] Increased Blood Eosinophil Count Is Related to Less Daily Physical Activity in Patients With Chronic Obstructive Pulmonary Disease
    Galera, Raul
    Mergelina, Cristina
    Casitas, Raquel
    Martinez-Ceron, Elisabet
    Rio, Francisco Garcia
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (12): : 837 - 839
  • [27] Variability of blood eosinophil count at stable-state in predicting exacerbation risk of chronic obstructive pulmonary disease
    Kwok, Wang Chun
    Chau, Chi Hung
    Tam, Terence Chi Chun
    Lam, Fai Man
    Ho, James Chung Man
    RESPIROLOGY, 2023, 28 : 66 - 67
  • [28] Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
    Kwok, Wang Chun
    Chau, Chi Hung
    Tam, Terence Chi Chun
    Lam, Fai Man
    Ho, James Chung Man
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 1145 - 1153
  • [29] EFFICACY OF TEZEPELUMAB IN ADULTS WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOOD EOSINOPHIL COUNT AND SMOKING HISTORY: PHASE 2A COURSE STUDY
    Han, Meilan K.
    Christenson, Stephanie
    Dransfield, Mark T.
    Bourbeau, Jean
    Bhutani, Mohit
    Nair, Parameswaran K.
    Singh, Dave
    Bafadhel, Mona
    Brightling, Christopher E.
    Ambrose, Christopher S.
    Kotalik, Ales
    Hellqvist, Asa
    Almqvist, Gun
    Sindhwani, Navreet S.
    Golabek, Monika
    Molfino, Nestor
    Ponnarambil, Sandhia
    CHEST, 2024, 166 (04) : 4681A - 4684A
  • [30] In the Phase 3 Boreas Trial, Baseline Blood Eosinophils and Baseline Fractional Exhaled Nitric Oxide Levels Predict the Response to Dupilumab in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
    Christenson, S.
    Hanania, N. A.
    Bhatt, S. P.
    Bafadhel, M.
    Rabe, K. F.
    Vogelmeier, C. F.
    Papi, A.
    Singh, D.
    Laws, E.
    Nivens, M. C.
    Bansal, A.
    Lu, X.
    Bauer, D.
    Maloney, J.
    Robinson, L. B.
    Abdulai, R. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345